GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » ROE % Adjusted to Book Value

ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) ROE % Adjusted to Book Value?

ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % for the quarter that ended in Jun. 2024 was -49.09%. ImmuneOnco Biopharmaceuticals (Shanghai)'s PB Ratio for the quarter that ended in Jun. 2024 was N/A. ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

ImmuneOnco Biopharmaceuticals (Shanghai) ROE % Adjusted to Book Value Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) ROE % Adjusted to Book Value Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data
Trend Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
- - - -17.69

ImmuneOnco Biopharmaceuticals (Shanghai) Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -18.76

Competitive Comparison of ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value

For the Biotechnology subindustry, ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value falls into.


;
;

ImmuneOnco Biopharmaceuticals (Shanghai) ROE % Adjusted to Book Value Calculation

ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-48.34% / N/A
=N/A

ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-49.09% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmuneOnco Biopharmaceuticals (Shanghai) ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:06996 HKSE:06978 HKSE:02181 HKSE:01521 HKSE:02509 HKSE:02487 HKSE:02137 HKSE:02566 HKSE:02563 HKSE:01167 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
01541:Hong Kong
Address
1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN
Website
http://cn.immuneonco.com
ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines